Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant Prostate Specific Antigen antibody (AA 150-250)

The Rabbit Monoclonal anti-Prostate Specific Antigen antibody has been validated for IHC (f). It is suitable to detect Prostate Specific Antigen in samples from Human.
Catalog No. ABIN7126557

Quick Overview for Recombinant Prostate Specific Antigen antibody (AA 150-250) (ABIN7126557)

Target

See all Prostate Specific Antigen (PSA) Antibodies
Prostate Specific Antigen (PSA)

Antibody Type

Recombinant Antibody

Reactivity

  • 237
  • 14
  • 13
  • 6
  • 1
  • 1
  • 1
Human

Host

  • 144
  • 92
  • 4
  • 3
  • 2
Rabbit

Clonality

  • 170
  • 76
Monoclonal

Conjugate

  • 141
  • 16
  • 11
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
This Prostate Specific Antigen antibody is un-conjugated

Application

  • 123
  • 83
  • 69
  • 62
  • 33
  • 25
  • 24
  • 24
  • 24
  • 12
  • 11
  • 10
  • 7
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 8
    • 8
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 150-250

    Specificity

    Prostate-specific antigen (PSA) is a single-chain glycoprotein of 237 amino acids containing approximately 8 % carbohydrate. It is a serine protease produced almost exclusively by prostatic epithelial cells. Immunohistochemically PSA is expressed in the highly specialized apically-superficial layer of female and male secretory cells of the prostate gland, and is readily demonstrated in adenocarcinomas of the prostate in about 99 % of the cases. There is a correlation between malignancy grade and intensity of staining, high grade carcinomas displaying weaker expression. About 1 % of poorly differentiated carcinomas have been negative for PSA. Due to the high specificity of PSA for prostatic glandular epithelium, it is very useful in identifying prostatic carcinoma in the prostate and in the adjacent organs often affected by epithelial malignancies, i.e. rectum and urinary bladder. PSA may be used in a panel together with NKX3.1 and Prostein, which are at least as sensitive and slightly more specific than PSA.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Synthetic peptide corresponding to PSA residues within aa150-250 of PSA was used as an immunogen.

    Isotype

    IgG
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: PC12 cells. Normal prostate or prostate carcinoma tissues.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    Prostate Specific Antigen (PSA)

    Alternative Name

    KLK3

    Background

    Antigen, prostate-specific (APS), Gamma-seminoprotein, hK3, Kallikrein related peptidase 3, Kallikrein-3 (KLK3), KLK2A1, P-30 antigen, Semenogelase, Seminin,Prostate Specific Antigen (PSA)
    Cellular localisation: Secreted

    Molecular Weight

    29kDa

    Gene ID

    354, 171995

    UniProt

    P07288

    Pathways

    Complement System
You are here:
Chat with us!